CRL logo

CRL EBIT

annual EBIT:

$219.40M-$498.59M(-69.44%)
December 28, 2024

Summary

  • As of today (May 29, 2025), CRL annual earnings before interest & taxes is $219.40 million, with the most recent change of -$498.59 million (-69.44%) on December 28, 2024.
  • During the last 3 years, CRL annual EBIT has fallen by -$335.22 million (-60.44%).
  • CRL annual EBIT is now -69.44% below its all-time high of $717.99 million, reached on December 30, 2023.

Performance

CRL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

quarterly EBIT:

$63.86M+$252.42M(+133.87%)
March 29, 2025

Summary

  • As of today (May 29, 2025), CRL quarterly earnings before interest & taxes is $63.86 million, with the most recent change of +$252.42 million (+133.87%) on March 29, 2025.
  • Over the past year, CRL quarterly EBIT has dropped by -$70.15 million (-52.35%).
  • CRL quarterly EBIT is now -77.17% below its all-time high of $279.70 million, reached on December 31, 2022.

Performance

CRL quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

TTM EBIT:

$149.25M-$70.15M(-31.97%)
March 29, 2025

Summary

  • As of today (May 29, 2025), CRL TTM earnings before interest & taxes is $149.25 million, with the most recent change of -$70.15 million (-31.97%) on March 29, 2025.
  • Over the past year, CRL TTM EBIT has dropped by -$537.33 million (-78.26%).
  • CRL TTM EBIT is now -80.24% below its all-time high of $755.44 million, reached on September 30, 2023.

Performance

CRL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CRL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-69.4%-52.4%-78.3%
3 y3 years-60.4%-46.9%-74.2%
5 y5 years-39.9%-9.4%-58.5%

CRL EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-69.4%at low-77.2%+133.9%-80.2%at low
5 y5-year-69.4%at low-77.2%+133.9%-80.2%at low
alltimeall time-69.4%+149.1%-77.2%+109.8%-80.2%+129.1%

CRL EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$63.86M(-133.9%)
$149.25M(-32.0%)
Dec 2024
$219.40M(-69.4%)
-$188.56M(-255.2%)
$219.40M(-66.3%)
Sep 2024
-
$121.53M(-20.3%)
$650.21M(-3.7%)
Jun 2024
-
$152.42M(+13.7%)
$675.30M(-1.6%)
Mar 2024
-
$134.01M(-44.7%)
$686.59M(-4.4%)
Dec 2023
$717.99M(+5.2%)
$242.25M(+65.2%)
$717.99M(-5.0%)
Sep 2023
-
$146.62M(-10.4%)
$755.44M(+1.6%)
Jun 2023
-
$163.71M(-1.0%)
$743.31M(+2.2%)
Mar 2023
-
$165.42M(-40.9%)
$727.42M(+6.6%)
Dec 2022
$682.28M(+23.0%)
$279.70M(+108.0%)
$682.28M(+18.1%)
Sep 2022
-
$134.48M(-9.0%)
$577.77M(-0.9%)
Jun 2022
-
$147.82M(+22.9%)
$583.01M(+0.7%)
Mar 2022
-
$120.28M(-31.3%)
$578.88M(+4.4%)
Dec 2021
$554.62M(+3.9%)
$175.19M(+25.4%)
$554.62M(-5.2%)
Sep 2021
-
$139.72M(-2.8%)
$585.01M(-2.4%)
Jun 2021
-
$143.69M(+49.6%)
$599.42M(+7.2%)
Mar 2021
-
$96.02M(-53.3%)
$559.04M(+4.8%)
Dec 2020
$533.55M(+46.2%)
$205.57M(+33.4%)
$533.55M(+16.5%)
Sep 2020
-
$154.14M(+49.2%)
$457.90M(+19.7%)
Jun 2020
-
$103.30M(+46.5%)
$382.69M(+6.5%)
Mar 2020
-
$70.53M(-45.7%)
$359.21M(-1.6%)
Dec 2019
$364.97M(+5.6%)
$129.93M(+64.6%)
$364.97M(+11.7%)
Sep 2019
-
$78.93M(-1.1%)
$326.83M(-3.4%)
Jun 2019
-
$79.83M(+4.7%)
$338.40M(-2.6%)
Mar 2019
-
$76.28M(-16.9%)
$347.50M(+0.6%)
Dec 2018
$345.45M(+5.7%)
$91.79M(+1.4%)
$345.45M(+4.5%)
Sep 2018
-
$90.50M(+1.8%)
$330.44M(+3.1%)
Jun 2018
-
$88.93M(+19.8%)
$320.55M(+1.5%)
Mar 2018
-
$74.23M(-3.3%)
$315.93M(-3.3%)
Dec 2017
$326.73M(+30.4%)
$76.78M(-4.8%)
$326.73M(+1.7%)
Sep 2017
-
$80.61M(-4.4%)
$321.19M(+6.7%)
Jun 2017
-
$84.32M(-0.8%)
$300.92M(+7.5%)
Mar 2017
-
$85.03M(+19.4%)
$279.90M(+11.7%)
Dec 2016
$250.63M(+19.1%)
$71.23M(+18.1%)
$250.63M(+7.5%)
Sep 2016
-
$60.34M(-4.7%)
$233.21M(+1.4%)
Jun 2016
-
$63.30M(+13.5%)
$229.88M(-0.6%)
Mar 2016
-
$55.76M(+3.6%)
$231.28M(+9.9%)
Dec 2015
$210.50M(+11.1%)
$53.81M(-5.6%)
$210.50M(+5.4%)
Sep 2015
-
$57.01M(-11.9%)
$199.65M(+5.3%)
Jun 2015
-
$64.70M(+85.0%)
$189.52M(+6.0%)
Mar 2015
-
$34.98M(-18.6%)
$178.73M(-5.7%)
Dec 2014
$189.54M(+19.0%)
$42.97M(-8.3%)
$189.54M(+9.9%)
Sep 2014
-
$46.88M(-13.0%)
$172.51M(+1.1%)
Jun 2014
-
$53.91M(+17.7%)
$170.68M(+5.9%)
Mar 2014
-
$45.79M(+76.6%)
$161.16M(+1.2%)
Dec 2013
$159.30M(-2.3%)
$25.93M(-42.4%)
$159.30M(-5.1%)
Sep 2013
-
$45.05M(+1.5%)
$167.88M(+5.1%)
Jun 2013
-
$44.39M(+1.1%)
$159.75M(-2.3%)
Mar 2013
-
$43.93M(+27.3%)
$163.44M(+0.2%)
Dec 2012
$163.09M
$34.51M(-6.5%)
$163.09M(-4.7%)
Sep 2012
-
$36.91M(-23.2%)
$171.19M(+0.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$48.08M(+10.3%)
$170.77M(-3.1%)
Mar 2012
-
$43.58M(+2.3%)
$176.15M(+0.5%)
Dec 2011
$175.25M(-158.7%)
$42.62M(+16.8%)
$175.25M(-175.9%)
Sep 2011
-
$36.48M(-31.8%)
-$230.83M(-12.0%)
Jun 2011
-
$53.46M(+25.3%)
-$262.25M(-8.4%)
Mar 2011
-
$42.68M(-111.7%)
-$286.21M(-4.2%)
Dec 2010
-$298.80M(-272.5%)
-$363.46M(-7278.7%)
-$298.80M(-401.9%)
Sep 2010
-
$5.06M(-82.8%)
$98.98M(-29.3%)
Jun 2010
-
$29.51M(-1.9%)
$139.93M(-14.2%)
Mar 2010
-
$30.08M(-12.4%)
$163.06M(-5.9%)
Dec 2009
$173.24M(-138.8%)
$34.33M(-25.4%)
$173.24M(-133.7%)
Sep 2009
-
$46.01M(-12.6%)
-$513.70M(+4.7%)
Jun 2009
-
$52.64M(+30.7%)
-$490.64M(+3.9%)
Mar 2009
-
$40.26M(-106.2%)
-$472.18M(+5.6%)
Dec 2008
-$447.00M(-289.9%)
-$652.61M(-1044.8%)
-$447.00M(-268.1%)
Sep 2008
-
$69.08M(-2.8%)
$265.98M(+2.1%)
Jun 2008
-
$71.10M(+8.6%)
$260.54M(+5.8%)
Mar 2008
-
$65.44M(+8.4%)
$246.16M(+4.6%)
Dec 2007
$235.43M(+25.1%)
$60.37M(-5.1%)
$235.43M(+6.9%)
Sep 2007
-
$63.63M(+12.2%)
$220.21M(+5.6%)
Jun 2007
-
$56.73M(+3.7%)
$208.50M(+4.5%)
Mar 2007
-
$54.70M(+21.1%)
$199.48M(+233.5%)
Dec 2006
$188.17M(+1.9%)
$45.15M(-13.0%)
$59.81M(+9.5%)
Sep 2006
-
$51.92M(+8.8%)
$54.61M(+4.7%)
Jun 2006
-
$47.70M(-156.1%)
$52.18M(-2.5%)
Mar 2006
-
-$84.96M(-312.7%)
$53.54M(-70.9%)
Dec 2005
$184.69M(+16.9%)
$39.95M(-19.3%)
$183.90M(+5.2%)
Sep 2005
-
$49.49M(+0.9%)
$174.84M(+3.6%)
Jun 2005
-
$49.06M(+8.1%)
$168.72M(+3.0%)
Mar 2005
-
$45.40M(+47.0%)
$163.87M(+3.7%)
Dec 2004
$157.99M(+14.0%)
$30.89M(-28.8%)
$157.99M(-2.8%)
Sep 2004
-
$43.37M(-1.9%)
$162.54M(+5.9%)
Jun 2004
-
$44.20M(+11.9%)
$153.42M(+6.4%)
Mar 2004
-
$39.52M(+11.5%)
$144.22M(+4.1%)
Dec 2003
$138.55M(+13.3%)
$35.44M(+3.5%)
$138.55M(+3.3%)
Sep 2003
-
$34.26M(-2.1%)
$134.06M(+1.3%)
Jun 2003
-
$35.01M(+3.4%)
$132.33M(+3.6%)
Mar 2003
-
$33.85M(+9.3%)
$127.70M(+4.4%)
Dec 2002
$122.27M(+35.4%)
$30.95M(-4.8%)
$122.27M(+7.5%)
Sep 2002
-
$32.52M(+7.0%)
$113.72M(+8.1%)
Jun 2002
-
$30.38M(+6.9%)
$105.21M(+5.9%)
Mar 2002
-
$28.41M(+26.8%)
$99.32M(+10.0%)
Dec 2001
$90.28M(+38.8%)
$22.41M(-6.7%)
$90.28M(+10.6%)
Sep 2001
-
$24.01M(-2.0%)
$81.65M(+8.2%)
Jun 2001
-
$24.49M(+26.4%)
$75.48M(+9.1%)
Mar 2001
-
$19.37M(+40.7%)
$69.20M(+6.4%)
Dec 2000
$65.06M(+51.4%)
$13.77M(-22.9%)
$65.06M(+26.8%)
Sep 2000
-
$17.85M(-2.0%)
$51.29M(+53.4%)
Jun 2000
-
$18.21M(+19.6%)
$33.45M(+119.6%)
Mar 2000
-
$15.23M
$15.23M
Dec 1999
$42.96M(+21.6%)
-
-
Dec 1998
$35.33M
-
-

FAQ

  • What is Charles River Laboratories International annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Charles River Laboratories International?
  • What is Charles River Laboratories International annual EBIT year-on-year change?
  • What is Charles River Laboratories International quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly EBIT year-on-year change?
  • What is Charles River Laboratories International TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM EBIT year-on-year change?

What is Charles River Laboratories International annual earnings before interest & taxes?

The current annual EBIT of CRL is $219.40M

What is the all time high annual EBIT for Charles River Laboratories International?

Charles River Laboratories International all-time high annual earnings before interest & taxes is $717.99M

What is Charles River Laboratories International annual EBIT year-on-year change?

Over the past year, CRL annual earnings before interest & taxes has changed by -$498.59M (-69.44%)

What is Charles River Laboratories International quarterly earnings before interest & taxes?

The current quarterly EBIT of CRL is $63.86M

What is the all time high quarterly EBIT for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly earnings before interest & taxes is $279.70M

What is Charles River Laboratories International quarterly EBIT year-on-year change?

Over the past year, CRL quarterly earnings before interest & taxes has changed by -$70.15M (-52.35%)

What is Charles River Laboratories International TTM earnings before interest & taxes?

The current TTM EBIT of CRL is $149.25M

What is the all time high TTM EBIT for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM earnings before interest & taxes is $755.44M

What is Charles River Laboratories International TTM EBIT year-on-year change?

Over the past year, CRL TTM earnings before interest & taxes has changed by -$537.33M (-78.26%)
On this page